Presentation is loading. Please wait.

Presentation is loading. Please wait.

A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases”  Monica Casiraghi, MD,

Published byLars-Göran Larsson Modified over 5 years ago

Similar presentations

Presentation on theme: "A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases”  Monica Casiraghi, MD,"— Presentation transcript:

1 A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases”  Monica Casiraghi, MD, Tommaso De Pas, MD, Patrick Maisonneuve, Eng., Daniela Brambilla, MSc, Barbara Ciprandi, MD, Domenico Galetta, MD, PhD, Alessandro Borri, MD, Roberto Gasparri, MD, Francesco Petrella, MD, Adele Tessitore, MD, Juliana Guarize, MD, Stefano Maria Donghi, MD, Giulia Veronesi, MD, Piergiorgio Solli, MD, Lorenzo Spaggiari, MD, PhD  Journal of Thoracic Oncology  Volume 6, Issue 8, Pages (August 2011) DOI: /JTO.0b013e e58 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Overall survival for all patients (A) and according to completeness of pulmonary resection (B) after a mean follow-up of 34 months. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Overall survival according to disease-free interval (A), lymph node involvement (B), histology (C), and epithelial tumors subtypes (D). Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Overall survival according to number of pulmonary metastasectomies after the last complete resection. Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Overall survival according to positron emission tomography (PET) (A) and chemotherapy (CT) (B). Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e e58) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases”  Monica Casiraghi, MD,"

Similar presentations

Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.

Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.
Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R
Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 

Sukki Cho, MD, Kyung-Min Ryu, MD, Yoon-Jin Hwang, MD, Eung Bae Lee, MD 
Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids  Piero Ferolla, MD, PhD, Niccolò Daddi, MD,

Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids  Piero Ferolla, MD, PhD, Niccolò Daddi, MD,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma  Marc de Perrot, MD, MSc, Ronald Feld, MD,

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma  Marc de Perrot, MD, MSc, Ronald Feld, MD,
Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy  Antonio Mazzella, MD, Alessandro Pardolesi,

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy  Antonio Mazzella, MD, Alessandro Pardolesi,
Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up  Marco Lucchi, MD, Franca Melfi, MD, Paolo.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 

James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program  Giulia Veronesi, MD, Massimo Bellomi, MD,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program  Giulia Veronesi, MD, Massimo Bellomi, MD,
Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.

Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and.
Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?  Francesco Leo, MD, Piergiorgio Solli,

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?  Francesco Leo, MD, Piergiorgio Solli,
Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series  Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,

Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series  Filippo Lococo, MD, Alfredo Cesario, MD, Giuseppe Cardillo,
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids  Piero Ferolla, MD, PhD, Niccolò Daddi, MD,

Tumorlets, Multicentric Carcinoids, Lymph-Nodal Metastases, and Long-Term Behavior in Bronchial Carcinoids  Piero Ferolla, MD, PhD, Niccolò Daddi, MD,

Similar presentations

Ads by Google